NCT05833009

Brief Summary

This clinical trial aims to test the effect of acupuncture in patients with schizophrenia-related central obesity. The main question it aims to answer is: • The effect, safety, and maintenance of acupuncture on schizophrenia-related central obesity. Participants will receive acupuncture treatment on purpose acupoints, acupuncture on acupoint peripheries, or fake acupuncture treatment on purpose acupoints for 20 weeks. And they need three follow-up visits during the treatment period and two follow-up visits after treatment. Researchers will compare the waist circumstance of these three groups to see if the purpose acupoints are valid for schizophrenia-related central obesity.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable schizophrenia

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2022

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

February 26, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 27, 2023

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2024

Completed
Last Updated

April 27, 2023

Status Verified

January 1, 2023

Enrollment Period

1.9 years

First QC Date

February 26, 2023

Last Update Submit

April 16, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from Baseline Waist Circumference at 8 weeks, 16 weeks, 20 weeks, 32 weeks, respectively

    Waist Circumference in centimiter

    Baseline, 8 weeks, 16 weeks, 20 weeks, 32 weeks

Secondary Outcomes (13)

  • Change from Baseline Body Weight Index at 8 weeks, 16 weeks, 20 weeks, 32 weeks, respectively

    Baseline, 8 weeks, 16 weeks, 20 weeks, 32 weeks

  • Change from Baseline Hip Circumference at 8 weeks, 16 weeks, 20 weeks, 32 weeks, respectively

    Baseline, 8 weeks, 16 weeks, 20 weeks, 32 weeks

  • Change from Baseline both Blood Pressure at 8 weeks, 16 weeks, 20 weeks, 32 weeks, respectively

    Baseline, 8 weeks, 16 weeks, 20 weeks, 32 weeks

  • Change from Baseline Blood Triglyceride at 16 weeks, 32 weeks, respectively

    Baseline, 16 weeks, 32 weeks

  • Change from Baseline Blood Total Cholesterol at 16 weeks, 32 weeks, respectively

    Baseline, 16 weeks, 32 weeks

  • +8 more secondary outcomes

Study Arms (3)

Acupuncture Group

EXPERIMENTAL

They receive actual acupuncture on purpose acupoints.

Device: Acupuncture

Sham Group

SHAM COMPARATOR

They receive actual acupuncture on points but not an acupoint around the purpose acupoints.

Device: Acupuncture

non-Acupuncture Group

SHAM COMPARATOR

They receive fake acupuncture (no needle) on purpose acupoints.

Device: Acupuncture

Interventions

All the groups receive respective treatment 3 times a week for the first eight weeks, twice a week for another 8 weeks, and once a week for the last 4 weeks.

Acupuncture GroupSham Groupnon-Acupuncture Group

Eligibility Criteria

Age25 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis with schizophrenia (Diagnostic and Statistical Manual of Mental Disorders: Fifth Edition);
  • Continuous use of antipsychotics for more than one year (may be combined with mood stabilizers, antianxiety medications, antidepressants, and benzodiazepines);
  • Abdominal obesity (central obesity): waist circumference ≥90cm for men or ≥85cm for women (Chinese Standard);
  • All participants and their guardians signed informed consent.

You may not qualify if:

  • Had various traditional Chinese medicine or chemical drugs, or acupuncture treatments for central obesity within two weeks before enrollment;
  • Pregnant or lactating woman;
  • Organic mental disorders and mental disorders induced by psychoactive and non-addictive substances;
  • With other diseases affecting their mental state (e.g., chronic obstructive pulmonary disease, coronary heart disease, angina pectoris, stroke, painful joint diseases, severe psychiatric diseases, tumors, and other physical diseases)
  • Severe liver and kidney insufficiency or other serious diseases of the system;
  • With a family history of metabolic diseases such as hypertension, diabetes, and hyperlipidemia;
  • Acupuncture dizziness, needle phobia, and other intolerant acupuncture treatment;
  • Patients who are not treated according to the regulations, cannot determine the efficacy or have incomplete data affecting the efficacy and safety evaluation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Shanghai Mental Health Center

Shanghai, Shanghai Municipality, 200030, China

RECRUITING

Shanghai Huangpu Mental Health Center

Shanghai, Shanghai Municipality, China

RECRUITING

MeSH Terms

Conditions

SchizophreniaObesity, Abdominal

Interventions

Acupuncture Therapy

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental DisordersObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 26, 2023

First Posted

April 27, 2023

Study Start

October 1, 2022

Primary Completion

September 1, 2024

Study Completion

September 30, 2024

Last Updated

April 27, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will share

Locations